Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation
- 30 April 2010
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 55 (4), 708-711
- https://doi.org/10.1053/j.ajkd.2009.08.011
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2009
- Successful Split Liver-Kidney Transplant for Factor H Associated Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2009
- Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutationPediatric Nephrology, 2008
- Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuriaBlood, 2008
- Proximal Cerebral Artery Stenosis in a Patient with Hemolytic Uremic Syndrome: Fig 1.American Journal of Neuroradiology, 2008
- Successful Liver-Kidney Transplantation in Two Children With aHUS Caused by a Mutation in Complement Factor HAmerican Journal of Transplantation, 2007
- Favorable Long-Term Outcome after Liver-Kidney Transplant for Recurrent Hemolytic Uremic Syndrome Associated with a Factor H MutationAmerican Journal of Transplantation, 2006
- Complement Factor H–Associated Atypical Hemolytic Uremic Syndrome in Monozygotic Twins: Concordant Presentation, Discordant Response to TreatmentAmerican Journal of Kidney Diseases, 2006
- A 20-Year Experience of Combined Liver/Kidney Transplantation for Primary Hyperoxaluria (PH1): The European PH1 Transplant Registry Experience 1984–2004American Journal of Nephrology, 2005
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001